• 1. Sleep Environment and the Risk of Sudden Infant Death Syndrome in an Urban Population: The Chicago Infant Mortality Study.

• 2. A Randomized, Community-Based Trial of Home Visiting to Reduce Blood Lead Levels in Children

• 3. AAP Policy Statement: Lead Poisoning

• 4. AAP Policy Statement: SIDS and Sleep Related Death

• 5. AAP Policy Statement: Breast feeding and Human Milk

• 6. AAP Policy Statement: Recommendations for the Prevention of Streptococcus pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)

• 7. AAP Practice Guideline: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

• 8. AAP Practice Guidelines: Acute Otitis Media

• 9. AAP Practice Guidelines: Bronchiolitis

• 10. AAP Practice Guidelines: UTI

• 11. AAP Technical Statement: Hyperbilirubinemia

• 12. Blood Cultures in the Emergency Department Evaluation of Childhood Pneumonia

• 13. Breastfeeding and Reduced Risk of Sudden Infant Death Syndrome: A Meta-Analysis

• 14. Cochran Review: Bronchodilators for Bronchiolitis

• 15. Early Intervention and Recovery Among Children With Failure to Thrive: Follow-up at Age 8

• 16. Failure to Thrive: When to Suspect Inborn Errors of Metabolism

• 17. Hypertonic saline for bronchiolitis

• 18. IV vs Oral antibiotics for UTI

• 19. JAMA Review: Acute Otitis Media

• 20. Low-Level Lead Exposure, Intelligence and Academic Achievement:

• 21. NEJM Review: SIDS

• 22. NEJM Review: Management of UTI in children

• 23. Nelson: Failure to Thrive

• 24. New evidence of risk factors for community-acquired pneumonia: a population-based study

• 25. Outcomes in a Population of Healthy Term and Near-Term Infants With Serum Bilirubin Levels of ³325 mmol/L (³19 mg/dL) Who Were Born in Nova Scotia, Canada, Between 1994 and 2000

• 26. Peds in Review: Infant Formula

• 27. Peds in Review: Pneumonia

• 28. Peds in Review: Breastfeeding

• 29. Peds in Review: Hyperbilirubinemia

• 30. Policy Statement: Use of Soy Protein-Based Formulas in Infant Feeding

• 31. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection?

• 32. Review: Failure to Thrive

• 33. Review: Lead Poisiong

• 34. Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections

• 35. Treatment of acute otitis media in children under 2 years of age.